These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8819923)

  • 1. [Blood lipid characteristics and the incidence of dyslipoproteinemia in the unorganized rural population of Moldova].
    Kishlaru LL
    Lik Sprava; 1995; (3-4):58-61. PubMed ID: 8819923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyslipoproteinemias in rural population of the Chuvash ASSR].
    Budylina GE; Vasil'eva NP; Saperov VN
    Ross Med Zh; 1992; (1):49-50. PubMed ID: 1535253
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of dyslipoproteinemias in 10- to 13-year-old schoolchildren (prospective epidemiological research)].
    Dorofeeva TG; Tubol IB; Zhukovskiĭ GS; Perova NV; Ruzhanskaia TV
    Pediatriia; 1987; (3):11-5. PubMed ID: 3601531
    [No Abstract]   [Full Text] [Related]  

  • 4. [The phenotypic characteristics and incidence of dyslipoproteinemias in diabetic patients].
    Kiriakov A; Koev D; Kavrykova Iu; Dimova Ia; Ovcharova N; Taneva T; Tinterova Z; Borisova A; Tsoneva G
    Probl Endokrinol (Mosk); 1990; 36(6):25-9. PubMed ID: 2087461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence Study.
    LaRosa JC; Chambless LE; Criqui MH; Frantz ID; Glueck CJ; Heiss G; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I12-29. PubMed ID: 3940679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dyslipoproteinemias in lupus erythematosus and scleroderma].
    Novikov AI; Dobrotina NA; Pavlova LT; Ezhova GP
    Vestn Dermatol Venerol; 1981 Jul; (7):4-7. PubMed ID: 7293472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different types of blood lipoproteins in psoriasis patients. 1. The relationship of dyslipoproteinemias due to disordered cholesterol transport and the course of psoriasis].
    Keshileva ZB; Kosukhin AB; Polevaia LG; Nusupova ZhA
    Vestn Dermatol Venerol; 1990; (2):7-11. PubMed ID: 2343674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipoproteinemia in North America: The Lipid Research Clinics Program Prevalence Study.
    Circulation; 1986 Jan; 73(1 Pt 2):I1-133. PubMed ID: 3940675
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
    Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disordered lipid metabolism in patients with arterial hypertension].
    Titkov IuS
    Vrach Delo; 1991 Aug; (8):53-5. PubMed ID: 1949734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsaturated fatty acids incorporated in HDL in hypo- and hyperalphalipoproteinemia--relation to the HDL-cholesterol level.
    Vecera R; Chmela Z; Hrebícek J; Skottová N
    Acta Univ Palacki Olomuc Fac Med; 1994; 137():35-8. PubMed ID: 7778503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and evaluation of dyslipoproteinemia.
    Hoeg JM
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):311-20. PubMed ID: 2192876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipoproteinemias after heart and heart-lung transplantation: potential relation to accelerated graft arteriosclerosis.
    Bilodeau M; Fitchett DH; Guerraty A; Sniderman AD
    J Heart Transplant; 1989; 8(6):454-9. PubMed ID: 2614546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of nutrition and other factors on the normalization and stabilization processes in dyslipoproteinemias].
    Verbitskaia AI; Zhukovsakiĭ GS; Olfer'ev AM; Grishenkov EA
    Ter Arkh; 1990; 62(9):105-8. PubMed ID: 2281390
    [No Abstract]   [Full Text] [Related]  

  • 17. Dyslipoproteinemia in black participants. The Lipid Research Clinics Program Prevalence Study.
    Wilcosky TC; Kwiterovich PO; Glueck CJ; Suchindran CM; Laskarzewski P; Christensen B; Tyroler HA
    Circulation; 1986 Jan; 73(1 Pt 2):I119-25. PubMed ID: 3940678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-related characteristics of the normal blood content of lipids and lipoproteins and in arterial hypertension].
    Tokar AV; Chaialo PP; Rudaia ES; Shevchenko VA
    Vutr Boles; 1983; 22(5):71-6. PubMed ID: 6673337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phospholipid characteristics of the HDLP2 and HDLP3 composition in dysalphalipoproteinemia].
    Gerasimova EN; Pham TM; Suchkova SN; Chepurnenko NV; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):86-93. PubMed ID: 7053079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipoproteinemias and manifestations of coronary heart disease. The Lipid Research Clinics Program Prevalence Study.
    Rubenstein C; Romhilt D; Segal P; Heiss G; Chambless LE; Boyle KE; Ekelund LG; Adolph R; Sheffield LT
    Circulation; 1986 Jan; 73(1 Pt 2):I91-9. PubMed ID: 3940687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.